MG
KALA icon

Marex Group’s KALA BIO KALA Stock Holding History

Marex Group’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-290
Closed -$35K – 1066
2025
Q3 		$35K Buy
+290
New +$144K ﹤0.01% 810

Other funds holding KALA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marex Group's KALA Position: Q4 2025 in Review

Marex Group sold out of KALA BIO (KALA) in Q4 2025, closing a stake of 290 shares — an estimated $35K sold.

Marex Group first reported a position in KALA in Q3 2025 and held it in 1 quarter. The position peaked at $35K in Q3 2025. 29 funds tracked by Wall St. Rank hold KALA as of Q4 2025.

  • Marex Group reported no remaining KALA BIO position as of Q4 2025 after selling out during the quarter.
  • Marex Group sold 290 KALA BIO shares in Q4 2025, an estimated $35K.
  • Marex Group first reported a position in KALA BIO in Q3 2025 and held it in 1 quarter.
  • Marex Group's KALA BIO position peaked at $35K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held KALA BIO as of Q4 2025.

Based on Marex Group's 13F filing for Q4 2025, filed 12 Feb 2026.